International Journal of Colorectal Disease

, Volume 28, Issue 2, pp 235–240 | Cite as

Increased risk of diabetes following perianal abscess: a population-based follow-up study

  • Po-Li Wei
  • Joseph J. Keller
  • Li-Jen Kuo
  • Herng-Ching Lin
Original Article



It remains unclear whether perianal abscess is a prediabetes condition or the initial presentation of type 2 diabetes. Using a population-based dataset, this study aimed to explore the risk of type 2 diabetes following perianal abscess.


We used data sourced from the Longitudinal Health Insurance Database 2000. In total, there were 1,419 adult patients with perianal abscess in the study group and 7,095 randomly selected subjects in the comparison group. Stratified Cox proportional hazards regressions were carried out to evaluate the association between being diagnosed with perianal abscess and receiving a subsequent diagnosis of diabetes within 5 years.


Of the total 8,514 sampled subjects, the incidence rate of diabetes per 100 person-years was 1.87 (95 % confidence interval (CI) = 1.74–2.01); the rate among patients with perianal abscess was 3.00 (95 % CI = 2.60–3.43) and was 1.65 (95 % CI = 1.52–1.79) among comparison patients. Stratified Cox proportional hazards analysis revealed that patients with perianal abscess were more likely to have received a diagnosis of diabetes than comparison patients (hazard ratio = 1.80, 95 % CI = 1.50–2.16, p < 0.001) during the 5-year follow-up period after censoring cases that died from nondiabetes causes and adjusting for patient geographic location, urbanization level, monthly income, hypertension, coronary heart disease, hyperlipidemia, obesity, and alcohol abuse/alcohol dependence syndrome at baseline.


Our results suggest that patients with perianal abscess have a higher chance of contracting type 2 diabetes mellitus within the first 5 years following their diagnosis.


Perianal abscess Diabetes Diabetes mellitus 



This study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health, Taiwan and managed by the National Health Research Institutes. The interpretations and conclusions contained herein do not represent those of the Bureau of National Health Insurance, Department of Health, or the National Health Research Institutes.

Conflict of interest

The authors have no conflicts of interest to declare.


  1. 1.
    Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M et al (2011) Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ (Clin res ed) 343:d4169CrossRefGoogle Scholar
  2. 2.
    Folsom AR, Rasmussen ML, Chambless LE et al (1999) Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) study investigators. Diabetes Care 22:1077–1083PubMedCrossRefGoogle Scholar
  3. 3.
    Kuusisto J, Mykkanen L, Pyorala K, Laakso M (1994) Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 25:1157–1164PubMedCrossRefGoogle Scholar
  4. 4.
    Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570–2581PubMedCrossRefGoogle Scholar
  5. 5.
    Barnett AH, Bain SC, Bouter P et al (2004) Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 351:1952–1961PubMedCrossRefGoogle Scholar
  6. 6.
    Mulnier HE, Seaman HE, Raleigh VS et al (2006) Mortality in people with type 2 diabetes in the UK. Diabet Med 23:516–521PubMedCrossRefGoogle Scholar
  7. 7.
    Hill JR (1967) Fistulas and fistulous abscesses in the anorectal region: personal experience in management. Dis Colon Rectum 10:421–434PubMedCrossRefGoogle Scholar
  8. 8.
    McElwain JW, MacLean MD, Alexander RM, Hoexter B, Guthrie JF (1975) Anorectal problems: experience with primary fistulectomy for anorectal abscess, a report of 1,000 cases. Dis Colon Rectum 18:646–649PubMedCrossRefGoogle Scholar
  9. 9.
    Read DR, Abcarian H (1979) A prospective survey of 474 patients with anorectal abscess. Dis Colon Rectum 22:566–568PubMedCrossRefGoogle Scholar
  10. 10.
    Rizzo JA, Naig AL, Johnson EK (2010) Anorectal abscess and fistula-in-ano: evidence-based management. Surg Clin North Am 90:45–68PubMedCrossRefGoogle Scholar
  11. 11.
    Devaraj B, Khabassi S, Cosman BC (2011) Recent smoking is a risk factor for anal abscess and fistula. Dis Colon Rectum 54:681–685PubMedCrossRefGoogle Scholar
  12. 12.
    Barrett WL, Callahan TD, Orkin BA (1998) Perianal manifestations of human immunodeficiency virus infection: experience with 260 patients. Dis Colon Rectum 141:606–611, Discussion, 611–12CrossRefGoogle Scholar
  13. 13.
    Winslett MC, Allan A, Ambrose NS (1988) Anorectal sepsis as a presentation of occult rectal and systemic disease. Dis Colon Rectum 31:597–600PubMedCrossRefGoogle Scholar
  14. 14.
    Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107PubMedCrossRefGoogle Scholar
  15. 15.
    Ozsari L, Karadurmus N, Sahin M, Uckaya G, Ural AU, Kutlu M (2010) Comparison of lymphomononuclear cell energy metabolism between healthy, impaired glucose intolerance and type 2 diabetes mellitus patients. Endocrine 37:135–139PubMedCrossRefGoogle Scholar
  16. 16.
    Cakmak A, Genç V, Akyol C, Kayaoğlu HA, Hazinedaroğlu SM (2008) Fournier’s gangrene: is it scrotal gangrene? Adv Ther 25:1065–1074PubMedCrossRefGoogle Scholar
  17. 17.
    Chung SD, Kang JH, Liao CH, Chiu KM, Lin HC (2011) Increased risk for cancer following erectile dysfunction: a nationwide population-based follow-up study. J Sex Med 8:1513–1520PubMedCrossRefGoogle Scholar
  18. 18.
    Lee EK, Cham TM, Tseng PL (2010) Using the pharmacoepidemiology approach to evaluate the first-year posttransplantation ambulatory health care cost from the Longitudinal Health Insurance Database (2001 to 2006) in Taiwan. Transplant Proc 42:957–960PubMedCrossRefGoogle Scholar
  19. 19.
    Kassi E, Pervanidou P, Kaltsas G, Chrousos G (2011) Metabolic syndrome: definitions and controversies. BMC Med 9:48PubMedCrossRefGoogle Scholar
  20. 20.
    McFarlane SI, Shin JJ, Rundek T, Bigger JT (2003) Prevention of type 2 diabetes. Curr Diab Rep 3:235–241PubMedCrossRefGoogle Scholar
  21. 21.
    Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J (2005) Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database Syst Rev 2:CD005270PubMedGoogle Scholar
  22. 22.
    Eisenhammer S (1956) The internal anal sphincter and the anorectal abscess. Surg Gynecol Obstet 103:501–506PubMedGoogle Scholar
  23. 23.
    Parks AG (1961) Pathogenesis and treatment of fistuila-in-ano. Br J Surg 1:463–469Google Scholar
  24. 24.
    Ramanujam PS, Prasad ML, Abcarian H, Tan AB (1984) Perianal abscesses and fistulas. A study of 1023 patients. Dis Colon Rectum 27:593–597PubMedCrossRefGoogle Scholar
  25. 25.
    Büyükaşik Y, Ozcebe OI, Sayinalp N et al (1998) Perianal infections in patients with leukemia: importance of the course of neutrophil count. Dis Colon Rectum 41:81–85PubMedCrossRefGoogle Scholar
  26. 26.
    Cohen JS, Paz IB, O’Donnell MR, Ellenhorn JD (1996) Treatment of perianal infection following bone marrow transplantation. Dis Colon Rectum 39:981–985PubMedCrossRefGoogle Scholar
  27. 27.
    Lejkowski M, Maheshwari A, Calhoun DA, Christensen RD, Skoda-Smith S, Dabrow S (2003) Persistent perianal abscess in early infancy as a presentation of autoimmune neutropenia. J Perinatol 23:428–430PubMedCrossRefGoogle Scholar
  28. 28.
    Laaksonen DE, Niskanen L, Nyyssönen K et al (2004) C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47:1403–1410PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Po-Li Wei
    • 1
    • 2
  • Joseph J. Keller
    • 3
  • Li-Jen Kuo
    • 1
    • 2
  • Herng-Ching Lin
    • 4
    • 5
  1. 1.Division of General Surgery, Department of SurgeryTaipei Medical University HospitalTaipeiTaiwan
  2. 2.Department of Surgery, School of Medicine, College of MedicineTaipei Medical UniversityTaipeiTaiwan
  3. 3.School of Public HealthTaipei Medical UniversityTaipeiTaiwan
  4. 4.School of Health Care AdministrationTaipei Medical UniversityTaipeiTaiwan
  5. 5.School of Health Care Administration, College of MedicineTaipei Medical UniversityTaipeiTaiwan

Personalised recommendations